Karen Linehan
Vermögen: 248 969 $ am 30.06.2026
Vermögen: 248 969 $ am 30.06.2026
Karen Linehan is currently an Independent Non-Executive Director at CNH Industrial NV since 2022, a Non-Executive Director at Global Antibiotic Research & Development Partnership, an Independent Director at Aelis Farma SA since 2022, a Member of the Supervisory Board at Sanofi-Aventis Deutschland GmbH, a Member of the Supervisory Board at Hoechst GmbH, and a Member of the Visitors Board at Georgetown University Law Center.
Former roles include Independent Non-Executive Director at VEON Ltd. from 2022 to 2024, Executive VP-Legal Affairs & General Counsel at Sanofi from 2014 to 2021, Associate at Townley & Updike from 1986 to 1990, and Member of the Supervisory Board at EUROAPI SA. Education includes undergraduate and graduate degrees from Georgetown University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.05.2026 | 22’170 ( 0% ) | 248 969 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AELIS FARMA | Direktor/Vorstandsmitglied | 01.01.2022 |
| CNH INDUSTRIAL N.V. | Direktor/Vorstandsmitglied | 11.03.2022 |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Direktor/Vorstandsmitglied | - |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Direktor/Vorstandsmitglied | - |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products | Direktor/Vorstandsmitglied | - |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| VEON LTD. | Direktor/Vorstandsmitglied | 31.05.2024 |
| SANOFI | General Counsel | 31.12.2021 |
| EUROAPI | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
VEON Ltd.
VEON Ltd. Wireless TelecommunicationsCommunications Provides wireless telecommunications services | Communications |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
CNH Industrial NV
CNH Industrial NV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets agricultural and construction equipment | Producer Manufacturing |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aelis Farma SA
Aelis Farma SA BiotechnologyHealth Technology Operates as a biotechnology company which develops drugs for brain diseases | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products | Health Technology |
EUROAPI SA
EUROAPI SA BiotechnologyHealth Technology Develops, manufactures, markets and distributes small molecule APIs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen